tiprankstipranks
Trending News
More News >
Cara Therapeutics (CARA)
NASDAQ:CARA
US Market
Advertisement

Cara Therapeutics (CARA) Income Statement

Compare
2,286 Followers

Cara Therapeutics Income Statement

Last quarter (Q1 2025), Cara Therapeutics's total revenue was $2.57M, an increase of 20.33% from the same quarter last year. In Q1, Cara Therapeutics's net income was $-4.91M. See Cara Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 7.14M$ 0.00$ 0.00$ 23.03M$ 135.08M
Gross Profit
$ 6.33M$ 0.00$ 0.00$ 21.47M$ 0.00
Operating Expenses
$ 62.11M$ 18.66M$ 21.19M$ 110.56M$ 128.68M
Depreciation and Amortization
$ 192.00K$ 95.00K$ 85.00K$ 1.55M$ 1.01M
EBITDA
$ -62.60M$ -17.25M$ -20.45M$ -86.89M$ 8.73M
Operating Income
$ -55.78M$ -18.66M$ -21.19M$ -89.08M$ 5.38M
Other Income/Expenses
$ -15.48M$ 1.32M$ 651.00K$ 642.00K$ 2.33M
Pretax Income
$ -71.27M$ -17.35M$ -20.54M$ -88.44M$ 7.72M
Net Income
$ -70.87M$ -17.35M$ -20.54M$ -88.44M$ 8.41M
Per Share Metrics
Basic EPS
$ -46.59$ -1.85$ -2.20$ -62.77$ 6.39
Diluted EPS
$ -46.59$ -1.85$ -2.20$ -62.77$ 6.32
Weighted Average Shares Outstanding
1.52M 9.36M 9.36M 1.41M 1.32M
Weighted Average Shares Outstanding (Diluted)
1.52M 9.36M 9.36M 1.41M 1.33M
Currency in USD

Cara Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis